ERIS LIFESCIENCES
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Eris Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.38₹ -22.35
As on Oct 31, 2025, 4:01 PM IST
Eris Lifesciences Price Performance
Today's LowToday's High
₹1,585.60₹1,625.45
₹1,596.85
52 Weeks' Low52 Weeks' High
₹1,130.05₹1,909.55
₹1,596.85
Open Price
₹1,623.55
Prev. Close
₹1,619.20
Volume
772
Over the last 5 years, the share price of Eris Lifesciences has gained 25.60% CAGR. Over the past year, the corresponding return has been 20.88%.
Eris Lifesciences’s current P/E of 56.20x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Eris Lifesciences Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Eris Lifesciences | 0.95 | -1.59 | -11.39 | 7.02 | 20.88 | 29.39 | 25.60 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Eris Lifesciences has gained 20.88% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Eris Lifesciences has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Eris Lifesciences Financials
Eris Lifesciences Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,602.9 | 1,617.17 |
| 10 | 1,598.07 | 1,610.42 |
| 20 | 1,598.01 | 1,612.17 |
| 50 | 1,665.58 | 1,640.54 |
| 100 | 1,696.84 | 1,634.18 |
| 200 | 1,527.48 | 1,552.07 |
Eris Lifesciences Share Holding Pattern
In the latest quarter, Eris Lifesciences saw a rise in promoter holding to 54.84%, while DII stake increased to 19.36%, FII holding fell to 7.21%, and public shareholding moved down to 18.57% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Eris Lifesciences Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 63,36,543 | 2.73 | 1,004.91 | |
| 24,59,629 | 1.62 | 390.07 | |
| 18,66,828 | 2.23 | 296.06 | |
| 12,31,000 | 0.78 | 195.22 | |
| 12,30,000 | 1.18 | 195.07 | |
| 12,24,569 | 1.03 | 194.2 | |
| 6,75,000 | 0.4 | 107.05 | |
| 6,27,786 | 0.85 | 99.56 | |
| 5,24,221 | 3.01 | 83.14 | |
| 4,71,821 | 0.96 | 74.83 |
* Excluding Index & Arbitrage Funds
Eris Lifesciences Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 13, 2025, 8:23 PM IST | Eris Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 11, 2025, 8:07 PM IST | Eris Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 02, 2025, 8:39 PM IST | Eris Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Aug 30, 2025, 9:06 PM IST | Eris Lifesciences - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Aug 26, 2025, 5:23 PM IST | Eris Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About Eris Lifesciences
Eris Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/2007 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24232GJ2007PLC049867 and registration number is 049867. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1697.75 Cr. and Equity Capital is Rs. 13.62 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressShivarth Ambit, Plot No. 142/2, Ramdas Road, Off SBR, Ahmedabad Gujarat 380054
- Contact
Management
- Mr. Amit BakshiChairperson & Managing Director
- Mr. Krishnakumar VaidyanathanCOO & Executive Director
- Mr. Inderjeet Singh NegiExecutive Director
- Mr. Kaushal ShahExecutive Director
- Mr. Rajeev DalalIndependent Director
- Mr. Sujesh VasudevanIndependent Director
- Ms. Kalpana UnadkatIndependent Director
- Mr. Prashant GuptaIndependent Director
FAQs on Eris Lifesciences Share Price
What is the share price of Eris Lifesciences?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Eris Lifesciences is ₹1,596.85 as on Oct 31, 2025.
What kind of stock is Eris Lifesciences?
The Eris Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Eris Lifesciences?
The market cap of Eris Lifesciences is ₹21,751.26 Cr as on Oct 31, 2025.
What are today's High and Low prices of Eris Lifesciences?
Today’s highest and lowest price of Eris Lifesciences are ₹1,625.45 and ₹1,585.60.
What are the 52 Week High and 52 Week Low of Eris Lifesciences?
The 52-week high/low is the highest and lowest price at which Eris Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Eris Lifesciences is ₹1,909.55 and 52-week low of Eris Lifesciences is ₹1,130.05 as on Oct 31, 2025.
How has the Eris Lifesciences performed historically in terms of returns?
The Eris Lifesciences has shown returns of -1.38% over the past day, -1.59% for the past month, -11.39% over 3 months, 20.88% over 1 year, 29.39% across 3 years, and 25.6% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Eris Lifesciences?
P/E ratio of and PB ratio of Eris Lifesciences are 56.20 and 7.85 on Oct 31, 2025. While the company gives a dividend yield of 0.46 per annum.
Eris Lifesciences News
✕
Market Pulse